Related Experiment Video
Updated: May 5, 2026
Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
Published on: May 6, 2020
Metabolomic profiles of cartilage and bone reflect tissue type, radiography-confirmed osteoarthritis, and spatial
Hope D Welhaven1, Ethan Viles2, Jenna Starke3
1Department of Chemistry & Biochemistry, Montana State University, Bozeman, MT, 59717, United States.
Abstract:
Osteoarthritis is the most common chronic joint disease, characterized by the abnormal remodeling of joint tissues including articular cartilage and subchondral bone. However, there are currently no therapeutic drug targets to slow the progression of disease because disease pathogenesis is largely unknown. Thus, the goals of this study were to identify metabolic differences between articular cartilage and subchondral bone, compare the metabolic shifts in osteoarthritic grade III and IV tissues, and spatially map metabolic shifts across regions of osteoarthritic hip joints. Articular cartilage and subchondral bone from 9 human femoral heads were obtained after total joint arthroplasty, homogenized and metabolites were extracted for liquid chromatography-mass spectrometry analysis. Metabolomic profiling revealed that distinct metabolic endotypes exist between osteoarthritic tissues, late-stage grades, and regions of the diseased joint. The pathways that contributed the most to these differences between tissues were associated with lipid and amino acid metabolism. Differences between grades were associated with nucleotide, lipid, and sugar metabolism. Specific metabolic pathways such as glycosaminoglycan degradation and amino acid metabolism, were spatially constrained to more superior regions of the femoral head. These results suggest that radiography-confirmed grades III and IV osteoarthritis are associated with distinct global metabolic and that metabolic shifts are not uniform across the joint. The results of this study enhance our understanding of osteoarthritis pathogenesis and may lead to potential drug targets to slow, halt, or reverse tissue damage in late stages of osteoarthritis.
Insights
Osteoarthritis (OA) involves distinct metabolic changes in joint tissues, varying by disease severity and location. Understanding these metabolic shifts offers potential new drug targets for OA.
Area of Science:
- Biochemistry
- Metabolomics
- Orthopedics
Background:
- Osteoarthritis (OA) is a prevalent joint disease marked by abnormal tissue remodeling, but its pathogenesis remains poorly understood.
- Current treatments for OA do not slow disease progression due to unknown pathogenic mechanisms.
- Identifying therapeutic targets is crucial for managing OA, especially in late stages.
Purpose of the Study:
- To identify metabolic differences between articular cartilage and subchondral bone in OA.
- To compare metabolic shifts in Grade III and IV OA tissues.
- To spatially map metabolic alterations across regions of osteoarthritic hip joints.
Main Methods:
- Collected human femoral heads (n=9) from total joint arthroplasty.
- Homogenized tissues and extracted metabolites.
- Performed liquid chromatography-mass spectrometry for metabolomic profiling.
Main Results:
- Distinct metabolic endotypes were observed between osteoarthritic tissues, late-stage grades, and joint regions.
- Lipid and amino acid metabolism were key differentiators between tissues.
- Nucleotide, lipid, and sugar metabolism distinguished between OA grades.
- Glycosaminoglycan degradation and amino acid metabolism were spatially localized to superior femoral head regions.
Conclusions:
- Radiography-confirmed Grade III and IV OA exhibit distinct global metabolic profiles.
- Metabolic shifts in OA are not uniform throughout the joint.
- Findings enhance understanding of OA pathogenesis and may reveal targets for novel OA therapies.
